Skip to content

Indocyanine Green fluorescence imaging for accurate intraoperative detection of early gastric cancer

Indocyanine Green (ICG) fluorescence imaging for accurate intraoperative detection of early gastric cancer - Indocyanine Green (ICG) fluorescence imaging for accurate intraoperative detection of early gastric cancer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041180133
Enrollment
150
Registered
2019-03-26
Start date
2016-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer or esophagogastric junction adenocarcinoma Early gastric cancer or esophagogastric junction adenocarcinoma

Interventions

Injection of ICG to the mucosal layer of stomach or esophagus

Sponsors

Tanaka Chie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients who are histologically proven gastric adenocarcinoma or esophagogastric junction adenocarcinoma 2. patients who are diagnosed clinical T1 according to the 14th edition of Japanese Classification of Gastric Carcinoma 3. patients who receive informed consent

Exclusion criteria

Exclusion criteria: 1. patients who have allergy to ICG 2. patients who have allergy to iodine 3. patients who are judged to be ineligible for subject by resercher

Design outcomes

Primary

MeasureTime frame
Differences in length between preoperatively-determined and actual surgical margins

Secondary

MeasureTime frame
Detection rate of ICG during gastrectomy, size of visualized ICG, morbidity of preoperative upper endoscopy, prevalence of adverse effects of ICG injection, operative time, intraoperative estimated blood loss, pathological findings (e.g. tumor depth, proximal and distal margin), postoperative morbidity rate, frequency of additional resection

Contacts

Public ContactChie Tanaka

Nagoya University Hospital

chtanaka@med.nagoya-u.ac.jp+81-52-744-2249

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026